Objectives
• Revisit the importance of early, holistic, management of people with type 2 diabetes
• Understand the role of Tirzepatide in early, holistic, management of people with type 2 diabetes
• Explore findings from a network meta-analysis of glucometabolic outcomes of GLP-1 receptor agonist-based therapies in people with type 2 diabetes
This Course For :
Physician
( Endocrinology & Metabolism , Family Medicine , Internal Medicine , General practitioner )
Resident / Fellow
( Endocrinology & Metabolism , Family Medicine , Internal Medicine , General practitioner )
Speaker
Prof Christophe De Block
Head of the Department of Endocrinology and Diabetology, Antwerp University Hospital, Belgium
Past President of Diabetes Liga,
Gent, Belgium
Prof Francesco Giorgino
Professor of Endocrinology and Chairman of the Department of Emergency and Organ Transplantation at the University of Bari Aldo Moro, Bari, Italy
Dr Jonathan Rachman
Medical Fellow
Lilly
Provided by :
Price
Course Fee
FREE
FREE
Contact Information
Organization : Virtual Medical AcademyPhone : 920008161
Email : [email protected]
Free
16 Apr 2024 To 16 Apr 2024 -
08:00 PM To 11:00 PM 
Certificate Available 
Online
- 474
Add to Calendar
04/16/2024 08:00 PM
04/16/2024 11:00 PM
Asia/ Riyadh
Tirzepatide (Mounjaro) as Part of Early Holistic Management of Type 2 Diabetes
Tirzepatide (Mounjaro) as Part of Early Holistic Management of Type 2 Diabetes
https://medicalacademy.org/portal/event/view/2158
